MYC and familial pancreatic carcinoma: We first evaluated the cytotoxic effect of c-Myc inhibition by using a c-Myc inhibitor and found that cell survival of two pancreatic cancer cells, namely PaCa44 and PT45, was impaired in a dose-dependent fashion by such treatment (Figure 1A).